ATE46920T1 - Viren und impfstoffe. - Google Patents

Viren und impfstoffe.

Info

Publication number
ATE46920T1
ATE46920T1 AT84100082T AT84100082T ATE46920T1 AT E46920 T1 ATE46920 T1 AT E46920T1 AT 84100082 T AT84100082 T AT 84100082T AT 84100082 T AT84100082 T AT 84100082T AT E46920 T1 ATE46920 T1 AT E46920T1
Authority
AT
Austria
Prior art keywords
viruses
methods
reassorted
equine influenza
rna7
Prior art date
Application number
AT84100082T
Other languages
English (en)
Inventor
David Andrew Dr Campbell
University
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE46920T1 publication Critical patent/ATE46920T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mechanical Operated Clutches (AREA)
  • Table Devices Or Equipment (AREA)
  • Insulated Conductors (AREA)
AT84100082T 1983-01-08 1984-01-05 Viren und impfstoffe. ATE46920T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838300467A GB8300467D0 (en) 1983-01-08 1983-01-08 Equine influenza
EP84100082A EP0113665B1 (de) 1983-01-08 1984-01-05 Viren und Impfstoffe

Publications (1)

Publication Number Publication Date
ATE46920T1 true ATE46920T1 (de) 1989-10-15

Family

ID=10536078

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84100082T ATE46920T1 (de) 1983-01-08 1984-01-05 Viren und impfstoffe.

Country Status (8)

Country Link
US (2) US4693893A (de)
EP (1) EP0113665B1 (de)
AT (1) ATE46920T1 (de)
CA (1) CA1261772A (de)
DE (1) DE3480005D1 (de)
GB (1) GB8300467D0 (de)
HK (1) HK8394A (de)
IE (1) IE56517B1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683137A (en) * 1982-04-16 1987-07-28 Cornell Research Foundation, Inc. Temperature sensitive reassortant viruses and a vaccine against equine influenza
GB8300467D0 (en) * 1983-01-08 1983-02-09 Wellcome Found Equine influenza
US4631191A (en) * 1985-06-20 1986-12-23 Biotechnology Research Partners, Ltd. Methods and compositions useful in preventing equine influenza
CA2164946A1 (en) * 1993-06-11 1994-12-22 Peter Palese High yielding influenza viruses
US6485729B1 (en) * 1993-09-13 2002-11-26 Protein Sciences Corporation Neuraminidase-supplemented compositions
EP0791055B1 (de) * 1994-11-10 2012-01-25 Baxter Healthcare S.A. Verfahren zur herstellung von biologischen produkten in protein-freier kultur
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
US5756341A (en) * 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US6482414B1 (en) * 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6177082B1 (en) 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6579528B1 (en) * 1998-08-13 2003-06-17 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
GB9923176D0 (en) 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
AU4930001A (en) * 2000-04-03 2001-10-15 Univ Pittsburgh Cold-adapted equine influenza viruses
EP1623015A4 (de) * 2003-05-15 2007-10-10 Univ Oklahoma State Ha1 des equine-2-influenzavirus exprimierender dna-impfstoff
TW200700079A (en) 2005-03-23 2007-01-01 Glaxosmithkline Biolog Sa Composition
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
WO2007051763A1 (en) * 2005-11-01 2007-05-10 Intervet International B.V. Prime boost vaccine for the protection of equines against equine influenza
MX2009000660A (es) 2006-07-17 2009-04-08 Glaxosmithkline Biolog Sa Vacuna de influenza.
US9452209B2 (en) 2007-04-20 2016-09-27 Glaxosmithkline Biologicals Sa Influenza vaccine
CN103602638A (zh) * 2013-11-20 2014-02-26 中国农业科学院哈尔滨兽医研究所 重组马流感病毒毒株、其制备方法及由其制备得到的疫苗
CN103898070A (zh) * 2014-03-04 2014-07-02 中国农业科学院哈尔滨兽医研究所 一种h3n8亚型马流感重组病毒样颗粒疫苗及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1067463A (en) * 1963-07-08 1967-05-03 Richard Laird Hall Preventive treatment for infectious viral equine respiratory disease
US3518347A (en) * 1965-05-28 1970-06-30 Inst Microbiologie Et D Hygien Vaccine for equine influenza
US4206287A (en) * 1972-07-21 1980-06-03 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines and their preparation
US4009258A (en) * 1972-09-25 1977-02-22 The Mount Sinai School Of Medicine Of The City University Of New York Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
CA1030449A (en) * 1972-09-25 1978-05-02 Edwin D. Kilbourne Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
US3869546A (en) * 1972-12-22 1975-03-04 Cutter Lab Adjuvant compositions and medicinal mixtures comprising them
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
US4024235A (en) * 1975-07-21 1977-05-17 Corning Glass Works Detection and quantitation of viral antibodies
US4338296A (en) * 1979-10-16 1982-07-06 Smithkline-Rit Influenza virus and process of producing a vaccine therefrom
US4485409A (en) * 1982-03-29 1984-11-27 Measuronics Corporation Data acquisition system for large format video display
EP0105364B1 (de) * 1982-04-16 1990-03-28 Cornell Research Foundation, Inc. Temperaturempfindliche reassortierende viren und impfstoff gegen pferdeinfluenza
US4683137A (en) * 1982-04-16 1987-07-28 Cornell Research Foundation, Inc. Temperature sensitive reassortant viruses and a vaccine against equine influenza
GB8300467D0 (en) * 1983-01-08 1983-02-09 Wellcome Found Equine influenza
US4552758A (en) * 1983-12-20 1985-11-12 St. Jude Children's Research Hospital Human use of avian-human reassortants as vaccines for influenza A virus
US4552757A (en) * 1983-12-20 1985-11-12 St. Jude Children's Research Hospital Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus

Also Published As

Publication number Publication date
IE840018L (en) 1984-07-08
US4693893A (en) 1987-09-15
HK8394A (en) 1994-02-04
US6045790A (en) 2000-04-04
EP0113665A2 (de) 1984-07-18
IE56517B1 (en) 1991-08-28
DE3480005D1 (en) 1989-11-09
CA1261772A (en) 1989-09-26
GB8300467D0 (en) 1983-02-09
EP0113665B1 (de) 1989-10-04
EP0113665A3 (en) 1986-12-30

Similar Documents

Publication Publication Date Title
ATE46920T1 (de) Viren und impfstoffe.
Ferko et al. Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice
ATE434035T1 (de) Lebender influenza impfstoff und verfahren zu seiner herstellung
FI903154A0 (fi) Kimeriska glykoproteiner innehaollande immunogeniska segment av glykoproteiner av maenniskans respiratory syncytial-virus.
DE69535940D1 (de) Verfahren zur Herstellung von biologischen Produkten in Protein-freiem Kultur
IT8247706A0 (it) Procedimento per la produzione di virus vaccini
ATE482267T1 (de) Tierzellen und verfahren für die replikation von influenza viren
NO975434L (no) Fremgangsmåte for fremstilling av influensa hemagglutinin multivalente vaksiner
MX2007007889A (es) Rescate del virus de influenza.
DE602004027537D1 (de)
NO904538L (no) Kimaere glykoproteiner inneholdende immunogene segmenter av humant parainfluensavirus type 3.
ATE104698T1 (de) Influenza-impfstoff.
GR33293B (el) Μεθοδος παρασκευης νεων εμβολιων κατα της γριππης.
PE72699A1 (es) Antigeno del rotavirus, vacuna y agente diagnostico para infeccion por rotavirus y un metodo para producir el antigeno
ATE375T1 (de) Grippevirusimpfstoff und verfahren zu seiner herstellung.
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
ATE132374T1 (de) Verhütung und behandlung einer retrovirenkrankheit
ATE4441T1 (de) Verfahren zur herstellung von influenza-avirusimpfst[mmen, virusimpfstamm und diesen enthaltender impfstoff.
Campbell Vaccines for equine influenza
GB1413401A (en) Influenza vaccine
Podchernyaeva et al. Molecular and biological properties of a variant of avian influenza A/Seal/Massachusetts/1/80 (H7N7) virus that is pathogenic for mice
UA24024C2 (uk) Вакциhа ротавірусhа іhактивоваhа для імуhізації твариh
GT198304126A (es) Produccion de proteinas del virus de herpes simplex
UA23820A (uk) Штам вірусу хвороби гамборо родини birnaviridae для виробництва вакцини проти хвороби гамборо

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time